Join us at the 7th Annual Practical Recommendations in Immuno and Molecular Oncology Meeting
PRIMO is a unique opportunity to receive CME/CE credits while staying ahead of the latest advances in immuno and molecular oncology.
The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that you and your patients will likely see in the upcoming year.
Target Audience
This activity has been designed to meet the educational needs of academic and community practitioners, as well as registered nurses, from all oncology specialties, treating all disease sites involved in the care of patients with cancer.
Learning
Objectives
Practical considerations of applying biomarkers and targeted therapy
Integration of immunotherapy, with a focus on novel management approaches
Patient selection, as well as timing and sequencing of therapy
Dealing with important trends, such as big data and defining value in cancer care
Co-Chairs
and Faculty
An elite faculty is in the process of being assembled for the 2022 Annual PRIMO Meeting by our steering committee, led by our co-chairs Dr. Rugo and Dr. Vose.
Sponsors and Exhibitors
The annual PRIMO Meeting offers a fantastic opportunity for industry to interact with leading multidisciplinary oncologists and stay up-to-date with the latest information regarding targeted and immunologic therapies.
Women in Oncology Award
The organizers of this award, PRIMO Education and Cancer Expert Now, thank all the past award recipients and nominees for their commitment to the advancement of cancer care and advocacy, and look forward to their continuing contributions to oncology in the future. In addition, the PRIMO organizers, co-chairs, and faculty are excited to review this coming year’s nominations.